Dentists in Skiatook, OK Accepting Medicare
7 Dentists found. Showing 1 - 7
 Drake K Sellmeyer, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 102 S Cherry St, Skiatook, OK 74070 Phone: 918-396-7373 Fax: 918-396-3797 |
Dr. Jaime Anne Parrish, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3433 E 181st St N, Skiatook, OK 74070 Phone: 402-650-3133 |
 Michael D Fowler, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 215 E 2nd, Skiatook, OK 74070 Phone: 918-396-2362 |
Dr. Bradford Raymond Williams, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1400 W 4th St, Skiatook, OK 74070 Phone: 918-396-3711 Fax: 918-396-1062 |
Alexander Williams Dentist Medicare: Not Enrolled in Medicare Practice Location: 8755 Battle Creek Ct, Skiatook, OK 74070 Phone: 918-396-3711 |
Dr. Bradford Raymond Williams Ii, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1400 W 4th St, Skiatook, OK 74070 Phone: 918-396-3711 Fax: 918-396-1062 |
Dr. G. Meghan Sellmeyer, D.D.S Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 102 S Cherry St, Skiatook, OK 74070 Phone: 918-396-7373 Fax: 918-396-3797 |
News Archive
Beacon Partners continues to grow to meet the needs of healthcare industry
As the healthcare community continues to ready itself to make the most of the stimulus funds in accordance with the ARRA, healthcare management consulting firm Beacon Partners' growth pattern continues with an aggressive hiring pattern to meet the needs of the healthcare industry.
Oncologists combine two different types of immunotherapy to successfully treat metastatic melanoma
Oncologists at the Fred Hutchinson Cancer Research Center have successfully treated a patient with metastatic melanoma by combining two different types of immunotherapy. Cassian Yee and colleagues describe their approach in a paper, "Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient," that will be published online May 30 in The Journal of Experimental Medicine.
Researchers identify potential drug target in skin for itchy feeling
No matter the trigger - bug bites, a medication side-effect or an itchy wound - the urge to scratch can be a real pain. Researchers at the Duke University Medical Center have identified a potential drug target in the skin for that itchy feeling.
Baxalta announces initial results from ADYNOVATE Phase 3 trial for treatment of hemophilia patients
Baxalta Incorporated, a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, today announced initial results from a Phase 3 clinical trial of ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated], an extended circulating half-life recombinant Factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].
› Verified 2 days ago
Dentists
Counselors
Pharmacists
Psychologists
Clinical Social Workers
Occupational Therapists